Navigation Links
Breakthrough in Pulmonary Drug Delivery will Bring Numerous In-Hospital Treatments to the Home
Date:12/19/2007

JEFFERSON, N.C., Dec. 19 /PRNewswire/ -- Next Safety, Inc., a leader in developing pulmonary drug delivery devices, today announced verification of a significant breakthrough in pulmonary science that provides high efficacy delivery of drugs to the lungs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070615/CLF038LOGO )

Advanced optical characterization techniques performed by a third party laboratory showed that 99.8% of the droplets delivered by Next Safety's pulmonary drug delivery devices were between one and three microns in diameter, and the droplets separated sufficiently in space and time to be absorbed into the alveoli of the lungs.

The company has already demonstrated more rapid delivery of nicotine to the bloodstream through the lungs than possible with cigarettes.

Next Safety's advance means that:

-- Drugs previously restricted to intravenous or oral delivery such as

antibiotics, analgesics, anti-emetics, peptides and proteins like

insulin and vaccines can be delivered to the human body directly

through the lungs.

-- The pharmaceutical industry can offer medications with systemic

delivery without needles, syringes and intravenous lines.

Four of the ten largest global pharmaceutical companies have expressed interest in the company's pulmonary business. Next Safety expects to begin a bidding process for its pulmonary business in early 2008.

Next Safety's immediate and ongoing research studies focus on the pulmonary delivery of nicotine, albuterol, tobramyacin and long chain peptide and protein molecules. Nicotine delivery and other clinical findings from brain imaging and arterial blood studies conducted in partnership with a major U.S. medical institution will be announced in the first quarter of 2008.

"Previous nicotine replacement products have helped millions of smokers worldwide. However the delivery mechanisms of these products cannot equal the power of nicotine delivered through the smoked cigarette. The next step in nicotine replacement treatment is the ability to deliver nicotine directly to the lung and brain, in the same manner as a cigarette, without the 4,000 harmful chemicals in tobacco" said Matthew Bars, MS, CTTS, an expert in nicotine addiction, key opinion leader and consultant to the pharmaceutical industry and Next Safety, Inc. Mr. Bars is the Director of the New York City Fire Department's Tobacco Cessation Program. "Pulmonary delivery of 'clean' nicotine would become the gold standard of nicotine replacement therapies. The Next Safety pulmonary nicotine delivery device has the potential of saving the lives of hundreds of millions of smokers worldwide" Bars concluded.

For more information about Next Safety, Inc. or the bidding process, please visit our website http://www.nextsafety.com.


'/>"/>
SOURCE Next Safety, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. On 30th Anniversary, Angioplasty Celebrated as Modern Medical Breakthrough in Stopping Heart Attack
2. drugstore.com and Revolution Health Group Announce Breakthrough Deal
3. New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs
4. CBaySystems Introduces CBayPraxis - A Breakthrough Solution Focused on Physician Practice Efficiency
5. Oosight Imaging System Enables a Breakthrough: The Viable Transfer of Genetic Material for Stem Cell Nuclear Reprogramming in Primates
6. Breakthrough in organ rejection diagnosis examines gene behavior
7. Safe Sex Passport Launches to Provide Breakthrough Protection Against STDs and HIV
8. Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome
9. Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
10. TIME Magazine Names GeneSearch(TM) One of the Top 10 Medical Breakthroughs in 2007
11. California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... , ... May 26, 2016 , ... ... intellectual property (IP) to its specialty academic programs. , Answering to the increasing ... existing certificate programs in health law, and environmental and land use law. , ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
(Date:5/26/2016)... ... 2016 , ... Leadership of Life Science Logistics (LSL), a ... earned its ISO 13485 certification, indicating the company’s quality control system for medical ... associated with ISO quality standard 13485. , BSI Group America, Inc., a ...
(Date:5/26/2016)... ... May 26, 2016 , ... Nike Yoga Camps ... from daily practices, arts & crafts, discussions, and games all geared towards enhancing ... Evans have combined backgrounds in kids’ yoga, collegiate sport yoga instruction, and global ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25,2016 FDA ... near-infrared Cellvizio platform for urological and surgical applications ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... milestone in the US with the 12 th ... Drug Administration (FDA). This new FDA clearance covers ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
(Date:5/25/2016)... -- According to market research "Global Insulin ... Forecast to 2022 - Industry Insights by Type (Insulin ... P&S Market Research, the global insulin delivery device market ... is expected to grow at a CAGR of 6.6% ... is expected to witness the fastest growth at a ...
Breaking Medicine Technology: